倾向评分匹配与粗化精确匹配比较机器人vs腹腔镜大范围肝切除术:4822例国际多中心研究
该国际多中心研究纳入59个中心2008—2021年4822例大范围肝切除术患者(R-MH 892例,L-MH 3930例),采用1:1倾向评分匹配和粗化精确匹配分析。结果表明R-MH与L-MH安全性相当,且R-MH出血量更少、Pringle阻断应用率和中转开腹率更低;肝硬化亚组中R-MH术后并发症率和住院时间也更优。
要点
- R-MH与L-MH安全性相当,围术期结局总体可比
- R-MH出血量、Pringle阻断率及中转开腹率均低于L-MH
- 肝硬化患者中R-MH术后并发症率更低、住院时间更短
核心结论
- R-MH与L-MH安全性相当,且与更少出血、更低Pringle阻断应用率及更低中转开腹率相关。
研究设计与样本
- 国际多中心数据库的post hoc分析,纳入59个中心2008—2021年行R-MH或L-MH的患者,共4822例(R-MH 892例,L-MH 3930例)。
- 采用1:1倾向评分匹配(PSM:841例R-MH vs 841例L-MH)和粗化精确匹配(CEM:237例R-MH vs 356例L-MH)以减小选择偏倚。
主要发现
- R-MH较L-MH出血量更少:PSM 200.0(IQR 100.0–450.0)vs 300.0(IQR 150.0–500.0)mL,P=0.012;CEM 170.0(IQR 90.0–400.0)vs 200.0(IQR 100.0–400.0)mL,P=0.006。
- R-MH较L-MH Pringle阻断应用率更低:PSM 47.1% vs 63.0%,P<0.001;CEM 54.0% vs 65.0%,P=0.007。
- R-MH较L-MH中转开腹率更低:PSM 5.1% vs 11.9%,P<0.001;CEM 5.5% vs 10.4%,P=0.04。
- 肝硬化亚组(1273例)中R-MH术后并发症率更低:PSM 19.5% vs 29.9%,P=0.02;CEM 10.4% vs 25.5%,P=0.02。
- 肝硬化亚组中R-MH术后住院时间更短:PSM 6.9(IQR 5.0–9.0)vs 8.0(IQR 6.0–11.3)天,P<0.001;CEM 7.0(IQR 5.0–9.0)vs 7.0(IQR 6.0–10.0)天,P=0.047。
临床怎么用
- 在大范围肝切除中,R-MH可作为与L-MH安全性相当的术式选择,并可能减少出血、Pringle阻断和中转开腹。
- 对合并肝硬化的患者,R-MH可能降低术后并发症率并缩短住院时间,术式选择时可结合中心经验与资源综合考虑。
局限性
- 本研究为对多中心数据库的post hoc分析,非随机对照设计,即使采用PSM和CEM仍可能存在未测量混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the outcomes between robotic major hepatectomy (R-MH) and laparoscopic major hepatectomy (L-MH). BACKGROUND: Robotic techniques may overcome the limitations of laparoscopic liver resection. However, it is unknown whether R-MH is superior to L-MH. METHODS: This is a post hoc analysis of a multicenter database of patients undergoing R-MH or L-MH at 59 international centers from 2008 to 2021. Data on patient demographics, center experience volume, perioperative outcomes, and tumor characteristics were collected and analyzed. Both 1:1 propensity-score matched (PSM) and coarsened-exact matched (CEM) analyses were performed to minimize selection bias between both groups. RESULTS: A total of 4822 cases met the study criteria, of which 892 underwent R-MH and 3930 underwent L-MH. Both 1:1 PSM (841 R-MH vs. 841 L-MH) and CEM (237 R-MH vs. 356 L-MH) were performed. R-MH was associated with significantly less blood loss {PSM:200.0 [interquartile range (IQR):100.0, 450.0] vs 300.0 (IQR:150.0, 500.0) mL; P = 0.012; CEM:170.0 (IQR: 90.0, 400.0) vs 200.0 (IQR:100.0, 400.0) mL; P = 0.006}, lower rates of Pringle maneuver application (PSM: 47.1% vs 63.0%; P < 0.001; CEM: 54.0% vs 65.0%; P = 0.007) and open conversion (PSM: 5.1% vs 11.9%; P < 0.001; CEM: 5.5% vs 10.4%, P = 0.04) compared with L-MH. On subset analysis of 1273 patients with cirrhosis, R-MH was associated with a lower postoperative morbidity rate (PSM: 19.5% vs 29.9%; P = 0.02; CEM 10.4% vs 25.5%; P = 0.02) and shorter postoperative stay [PSM: 6.9 (IQR: 5.0, 9.0) days vs 8.0 (IQR: 6.0 11.3) days; P < 0.001; CEM 7.0 (IQR: 5.0, 9.0) days vs 7.0 (IQR: 6.0, 10.0) days; P = 0.047]. CONCLUSIONS: This international multicenter study demonstrated that R-MH was comparable to L-MH in safety and was associated with reduced blood loss, lower rates of Pringle maneuver application, and conversion to open surgery.
引用
- Liu Q, Zhang W, Zhao JJ, et al. Propensity-score Matched and Coarsened-exact Matched Analysis Comparing Robotic and Laparoscopic Major Hepatectomies: An International Multicenter Study of 4822 Cases. Ann Surg. 2023. PMID: 37058429. doi:10.1097/SLA.0000000000005855
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。